Case number 1:23-cv-00013
Novo Nordisk, Inc. et al v. Viatris Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 28, 2023 | 38 | REPORT of Rule 26(f) Planning Meeting. (White, Brandon) (Entered: 06/28/2023) (11) |
| Jun 15, 2023 | 37 | ORDER EXTENDING DEADLINES. Joint Report of Initial Planning Meetingis extended through and until June 28, 2023. Signed by Chief District Judge Thomas S Kleeh on 6/15/2023. (snc) (Entered: 06/15/2023) (1) |
| Jun 14, 2023 | 36 | Joint MOTION for Extension of Time to File Joint Planning Report by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Proposed Order)(White, Brandon) (Entered: 06/14/2023) (Proposed Order) (1) |
| Jun 14, 2023 | 36 | Joint MOTION for Extension of Time to File Joint Planning Report by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Proposed Order)(White, Brandon) (Entered: 06/14/2023) (Main Document) (3) |
| Jun 6, 2023 | 35 | CERTIFICATE OF SERVICE by Novo Nordisk A/S, Novo Nordisk, Inc. for Plaintiffs' Initial Disclosures. (Law, Sandra) (Entered: 06/06/2023) (2) |
| Jun 5, 2023 | 34 | ORDER DENYING JOINT MOTION FOR EXTENSION [ECF No. 33 ]. Signed by Chief District Judge Thomas S Kleeh on 6/5/2023. (hrc) (Entered: 06/05/2023) (1) |
| Jun 1, 2023 | 33 | Joint MOTION for Extension of Time to File Joint Report of Initial Planning Meeting by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Proposed Order)(White, Brandon) (Entered: 06/01/2023) (Proposed Order) (2) |
| Jun 1, 2023 | 33 | Joint MOTION for Extension of Time to File Joint Report of Initial Planning Meeting by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Proposed Order)(White, Brandon) (Entered: 06/01/2023) (Main Document) (2) |
| May 18, 2023 | 32 | ORDER EXTENDING DEADLINES. Rule 26 Meeting to be held by 5/31/2023. Rule 26 Meeting Report due by 6/14/2023. Signed by Chief District Judge Thomas S Kleeh on 5/18/2023. (snc) (Entered: 05/18/2023) (1) |
| May 17, 2023 | 31 | Joint MOTION for Extension of Time to File Joint Report of Initial Planning Meeting by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Proposed Order Proposed Order)(White, Brandon) (Entered: 05/17/2023) (Proposed Order Proposed Order) (1) |
| May 17, 2023 | 31 | Joint MOTION for Extension of Time to File Joint Report of Initial Planning Meeting by Mylan Pharmaceuticals Inc., Viatris Inc.. (Attachments: # 1 Proposed Order Proposed Order)(White, Brandon) (Entered: 05/17/2023) (Main Document) (2) |
| May 4, 2023 | 30 | ORDER EXTENDING DEADLINES. Rule 26 Meeting to be held by 5/17/2023. Rule 26 Meeting Report due by 5/31/2023. Signed by Chief District Judge Thomas S Kleeh on 5/4/2023. (dk) (Entered: 05/04/2023) (1) |
| May 3, 2023 | 29 | Joint MOTION for Extension to hold Initial Planning Meeting and to submit Joint Report of Initial Planning Meeting by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 05/03/2023) (Proposed Order) (1) |
| May 3, 2023 | 29 | Joint MOTION for Extension to hold Initial Planning Meeting and to submit Joint Report of Initial Planning Meeting by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 05/03/2023) (Main Document) (2) |
| Apr 21, 2023 | 28 | ANSWER to 25 Answer to Complaint, Counterclaim Answer to Counterclaim by Novo Nordisk A/S, Novo Nordisk, Inc..(Law, Sandra) (Entered: 04/21/2023) (13) |
| Apr 3, 2023 | 27 | FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 5/3/2023. Rule 26 Meeting Report due by 5/17/2023. Discovery due by 6/5/2023. Signed by Chief District Judge Thomas S Kleeh on 4/3/2023. (dk) (Entered: 04/03/2023) (6) |
| Mar 31, 2023 | 26 | Corporate Disclosure Statement by Mylan Pharmaceuticals Inc., Viatris Inc.. (White, Brandon) (Entered: 03/31/2023) (2) |
| Mar 31, 2023 | 24 | NOTICE of Appearance by Brandon M. White on behalf of All Defendants (White, Brandon) (Entered: 03/31/2023) (2) |
| Mar 31, 2023 | 25 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Defendants by Mylan Pharmaceuticals Inc., Viatris Inc..(White, Brandon) (Entered: 03/31/2023) (30) |
| Feb 17, 2023 | 16 | ORDER: Granting 6 Motion for Leave to Appear Pro Hac Vice of Nicholas Groombridge. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 17 | ORDER: Granting 7 Motion for Leave to Appear Pro Hac Vice of Jenny C. Wu. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 18 | ORDER: Granting 8 Motion for Leave to Appear Pro Hac Vice of Joshua Reich. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 19 | ORDER: Granting 9 Motion for Leave to Appear Pro Hac Vice of Josephine Young. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 20 | ORDER: Granting 10 Motion for Leave to Appear Pro Hac Vice of Daniel J. Klein. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 21 | ORDER: Granting 11 Motion for Leave to Appear Pro Hac Vice of Naz E. Wehrli. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 22 | ORDER: Granting 12 Motion for Leave to Appear Pro Hac Vice of Peter Sandel. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 17, 2023 | 23 | ORDER: Granting 13 Motion for Leave to Appear Pro Hac Vice of Scott E. Miller. Signed by Chief District Judge Thomas S Kleeh on 2/17/2023. (hrc) (Entered: 02/17/2023) (1) |
| Feb 8, 2023 | 13 | MOTION for Leave to Appear Pro Hac Vice of Scott E. Miller by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Feb 8, 2023 | 15 | WAIVER OF SERVICE Returned Executed by Novo Nordisk, Inc., Novo Nordisk A/S. All Defendants. (Companion, James) (Entered: 02/08/2023) (1) |
| Feb 8, 2023 | 14 | Pro Hac Vice filing fees for N. Groombridge, J. Wu, J. Reich, J. Young, D. Klein, N. Wehrli, P. Sandel, and S. Miller received in the amount of $1600.00, receipt number WVNC003597. (hrc) (Entered: 02/08/2023) (0) |
| Feb 8, 2023 | 13 | MOTION for Leave to Appear Pro Hac Vice of Scott E. Miller by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 12 | MOTION for Leave to Appear Pro Hac Vice of Peter Sandel by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 11 | MOTION for Leave to Appear Pro Hac Vice of Naz E. Wehrli by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 10 | MOTION for Leave to Appear Pro Hac Vice of Daniel J. Klein by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 9 | MOTION for Leave to Appear Pro Hac Vice of Josephine Young by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 8 | MOTION for Leave to Appear Pro Hac Vice of Joshua Reich by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 7 | MOTION for Leave to Appear Pro Hac Vice of Jenny C. Wu by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 6 | MOTION for Leave to Appear Pro Hac Vice of Nicholas Groombridge by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Main Document) (2) |
| Feb 8, 2023 | 12 | MOTION for Leave to Appear Pro Hac Vice of Peter Sandel by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Feb 8, 2023 | 8 | MOTION for Leave to Appear Pro Hac Vice of Joshua Reich by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Feb 8, 2023 | 6 | MOTION for Leave to Appear Pro Hac Vice of Nicholas Groombridge by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Feb 8, 2023 | 7 | MOTION for Leave to Appear Pro Hac Vice of Jenny C. Wu by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Feb 8, 2023 | 11 | MOTION for Leave to Appear Pro Hac Vice of Naz E. Wehrli by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Feb 8, 2023 | 9 | MOTION for Leave to Appear Pro Hac Vice of Josephine Young by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Feb 8, 2023 | 10 | MOTION for Leave to Appear Pro Hac Vice of Daniel J. Klein by Novo Nordisk A/S, Novo Nordisk, Inc.. (Attachments: # 1 Proposed Order)(Companion, James) (Entered: 02/08/2023) (Proposed Order) (1) |
| Jan 30, 2023 | 5 | VERIFICATION OF ATTORNEY ADMISSION to Attorneys N. Groombridge, P. Sandel, D. Klein, J. Wu, J. Reich, N. Wehrli, and J. Young. (dk) (Entered: 01/30/2023) (1) |
| Jan 30, 2023 | 4 | REPORT to USPTO on the filing or determination of an action regarding re 1 Complaint. (dk) (Entered: 01/30/2023) (1) |
| Jan 27, 2023 | 3 | PLAINTIFFS' FED.R.CIV.P. 7.1 STATEMENT by Novo Nordisk A/S, Novo Nordisk, Inc. (dk) (Entered: 01/30/2023) (2) |
| Jan 27, 2023 | 2 | SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by Novo Nordisk A/S, Novo Nordisk, Inc. (dk) (Entered: 01/30/2023) (2) |
| Jan 27, 2023 | 1 | Complaint* (1) |
